About the Product

Description


Ofloglee 300 LB Tablet containing Ofloxacin and Lactobacillus is used for the management of bacterial infections and digestive imbalance. It helps support infection control while maintaining healthy intestinal flora.

Ofloxacin works as a fluoroquinolone antibiotic that inhibits bacterial growth, while Lactobacillus supports restoration of beneficial gut bacteria and digestive balance.

The tablet is widely prescribed in gastroenterology and general medicine practice for infection-associated digestive disorders, leading to consistent prescription demand.

With increasing prevalence of gastrointestinal infections and growing awareness of probiotic support during antibiotic therapy, this product offers strong business potential for retailers and distributors. Its combined anti-infective and probiotic action, broad clinical relevance, and steady market demand make it a reliable product for growth in the gastroenterology segment.

Some patients may experience nausea, abdominal discomfort, diarrhea, headache, dizziness, or altered taste. Rarely, allergic reactions, tendon-related problems, or nervous system disturbances may occur and require medical attention.

Ofloglee 300 LB Tablet is indicated for bacterial gastrointestinal infections, diarrhea, urinary tract infections, respiratory tract infections, and other susceptible bacterial infections. It helps eliminate harmful bacteria, reduce infection-related symptoms, and support restoration of normal intestinal flora.

This medicine should be used under medical supervision. Complete the full prescribed course to help prevent antibiotic resistance. Use cautiously in elderly patients and those with kidney disorders or a history of tendon-related conditions.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ofloglee 300 LB Tablet in the PCD pharma franchise market?

Ofloglee 300 LB Tablet, containing Ofloxacin 300mg and Lactobacillus 60 Million cells, has strong demand in the gastroenterology and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastrointestinal and infection management portfolios.

Why should medical distributors include Ofloglee 300 LB Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for antibiotic and probiotic combination therapies used in bacterial gastrointestinal infections, diarrhea, and digestive disturbances. The addition of Lactobacillus helps support healthy gut flora balance during antibiotic therapy, strengthening a comprehensive gastro care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Ofloglee 300 LB Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ofloglee 300 LB Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Ofloglee 300 LB Tablet distribution?

Wholesalers and medical agencies benefit from steady prescription demand, strong retail market movement, reliable supply chain support, and good margins when partnering for Ofloglee 300 LB Tablet distribution.

How can I become a distributor or franchise partner for Ofloglee 300 LB Tablet?

Medical distributors, stockists, and wholesalers interested in Ofloglee 300 LB Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.